Combined Hormone Pills: Physician Practice Patterns in Two Catholic Affiliated Community Hospitals [30E

Abstract

INTRODUCTION: Our objective is to explore primary healthcare physicians prescribing patterns of oral combined hormone pills (CHP) in a community health setting specifically associated with a catholic hospital. CHP refers to any oral medication that contains both an estrogen and a progesterone. METHODS: Primary care physicians associated with two catholic affiliated community hospitals in Chicago, IL were identified. Physicians received an online survey via email which was resulted anonymously. RESULTS: A total of 45 respondents; 49% Internal Medicine, 27% OB/GYN, and 24% Family Practice. 64% had prescribed CHPs within the last year. Correct identification of contraindications to therapy as recommended per CDC was on average 73.47%. 68% of respondents routinely document discussion of VTE risk. Most commonly prescribed concentration of ethinyl estradiol is 20-25 mcg (60%) n=25. Only 54% of respondents prescribe < 7 refills. 58% of respondents continue to prescribe bi or triphasic pills. 33% of respondents require a pelvic exam for refill, 50% require an in-person appointment for refills. When prescribing for pregnancy prevention (n=23) 39% of respondents counsel a Sunday start. CONCLUSION: Catholic affiliated hospital physicians do prescribe CHPs. Important knowledge gaps exist within community physicians with regards to eligibility criteria for CHPs. There has been slow adaptation of recommended standards of practice with respect to CHPs such as number of refills given, physical exam requirements and other recommendations set forth by current population based research. Patient education by community physicians is lacking with regards to benefits of CHPs.